Last reviewed · How we verify

Silver sulfadiazine ointment

SCARM Institute, Tabriz, Iran · FDA-approved active Small molecule

Silver sulfadiazine ointment is a Topical antimicrobial agent Small molecule drug developed by SCARM Institute, Tabriz, Iran. It is currently FDA-approved for Burn wound infection prevention and treatment, Infected wounds and ulcers, Prevention of infection in minor cuts and abrasions. Also known as: Silvazine, Flamazine, Silvadene, Sliverex.

Silver sulfadiazine releases silver ions that inhibit bacterial cell wall synthesis and disrupt microbial DNA, while sulfadiazine inhibits folate synthesis in bacteria.

Silver sulfadiazine releases silver ions that inhibit bacterial cell wall synthesis and disrupt microbial DNA, while sulfadiazine inhibits folate synthesis in bacteria. Used for Burn wound infection prevention and treatment, Infected wounds and ulcers, Prevention of infection in minor cuts and abrasions.

At a glance

Generic nameSilver sulfadiazine ointment
Also known asSilvazine, Flamazine, Silvadene, Sliverex, SSD
SponsorSCARM Institute, Tabriz, Iran
Drug classTopical antimicrobial agent
TargetBacterial cell wall and DNA; dihydropteroate synthase
ModalitySmall molecule
Therapeutic areaDermatology / Wound Care
PhaseFDA-approved

Mechanism of action

Silver sulfadiazine is a topical antimicrobial agent combining silver's broad-spectrum bactericidal properties with sulfadiazine's sulfonamide mechanism. Silver ions denature bacterial proteins and interfere with cellular respiration, while sulfadiazine competitively inhibits bacterial dihydropteroate synthase, blocking folate synthesis essential for bacterial growth. This dual mechanism provides synergistic antimicrobial activity against a wide range of gram-positive and gram-negative bacteria.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Silver sulfadiazine ointment

What is Silver sulfadiazine ointment?

Silver sulfadiazine ointment is a Topical antimicrobial agent drug developed by SCARM Institute, Tabriz, Iran, indicated for Burn wound infection prevention and treatment, Infected wounds and ulcers, Prevention of infection in minor cuts and abrasions.

How does Silver sulfadiazine ointment work?

Silver sulfadiazine releases silver ions that inhibit bacterial cell wall synthesis and disrupt microbial DNA, while sulfadiazine inhibits folate synthesis in bacteria.

What is Silver sulfadiazine ointment used for?

Silver sulfadiazine ointment is indicated for Burn wound infection prevention and treatment, Infected wounds and ulcers, Prevention of infection in minor cuts and abrasions.

Who makes Silver sulfadiazine ointment?

Silver sulfadiazine ointment is developed and marketed by SCARM Institute, Tabriz, Iran (see full SCARM Institute, Tabriz, Iran pipeline at /company/scarm-institute-tabriz-iran).

Is Silver sulfadiazine ointment also known as anything else?

Silver sulfadiazine ointment is also known as Silvazine, Flamazine, Silvadene, Sliverex, SSD.

What drug class is Silver sulfadiazine ointment in?

Silver sulfadiazine ointment belongs to the Topical antimicrobial agent class. See all Topical antimicrobial agent drugs at /class/topical-antimicrobial-agent.

What development phase is Silver sulfadiazine ointment in?

Silver sulfadiazine ointment is FDA-approved (marketed).

What are the side effects of Silver sulfadiazine ointment?

Common side effects of Silver sulfadiazine ointment include Local skin irritation or rash, Argyria (blue-gray skin discoloration with prolonged use), Allergic contact dermatitis, Leukopenia (rare, with systemic absorption).

What does Silver sulfadiazine ointment target?

Silver sulfadiazine ointment targets Bacterial cell wall and DNA; dihydropteroate synthase and is a Topical antimicrobial agent.

Related